Major Vault Protein (MVP) (Middle Region) Peptide
MVP
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5511367
Aperçu rapide pour Major Vault Protein (MVP) (Middle Region) Peptide (ABIN5511367)
Antigène
MVP
(Major Vault Protein (MVP))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- ELLNKGQDPL ADRGEKDTAK SLQPLAPRNK TRVVSYRVPH NAAVQVYDYR
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MVP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MVP (Major Vault Protein (MVP))
-
Sujet
-
This gene encodes the major component of the vault complex. Vaults are multi-subunit ribonucleoprotein structures that may be involved in nucleo-cytoplasmic transport. The encoded protein may play a role in multiple cellular processes by regulating the MAP kinase, JAK/STAT and phosphoinositide 3-kinase/Akt signaling pathways. The encoded protein also plays a role in multidrug resistance, and expression of this gene may be a prognostic marker for several types of cancer. Alternatively spliced transcript variants have been observed for this gene.
Alias Symbols: MVP,LRP,
Protein Size: 893 -
ID gène
- 9961
-
NCBI Accession
- NP_059447
-
UniProt
- Q14764
Antigène
-
Vous êtes ici:
